The methylation levels of the SLC6a2 promoter as a whole in Regions A and B analysed using the EpiTYPER method were not significantly different between subjects with MDD or panic disorder and healthy controls (Figures 3&4). This evidence concerns the gene SLC6A2 and major depressive disorder.